breast cancer

Excerpt of an op-ed by Susan G. Komen President and CEO Judith A. Salerno published in The Huffington Post . As I conducted numerous media interviews about the continued need for research, education, treatment support, and advocacy, it occurred to me that it would be great if we were talking about breast cancer like this every day of the year. It’s really quite simple. Breast cancer doesn’t know (and doesn’t care) that it’s October, because breast cancer is diagnosed and kills women and men every day of every month of every year. Every 19 seconds, somewhere in the world, a person has a new diagnosis of breast cancer. In the U.S., a woman is diagnosed every two minutes, and one dies every 13...

Research!America’€™s newest fact sheet series highlights the personal stories of medical research and the importance of increasing the NIH budget in FY15. We hope you will share these fact sheets with your representatives or congressional candidates, or take it with you on Hill or in-district visits. No one who reads these stories can doubt the significance of medical progress. A stronger investment in research is needed now more than ever! Here are their stories: John Hudson Dilgen, Epidermolysis Bullosa Steve DeWitte, Parkinson’s disease Victor Medina, Traumatic Brain Injury Carrie Scott, Multiple Sclerosis Max Hasenauer, X-linked agammaglobulinemia Michael Moskowitz, non-Hodgkin’s...

It’€™s Breast Cancer Awareness Month! Although many great strides in new treatments and therapies for breast cancer have been made, patients and their families are still waiting desperately for a cure. According to the American Cancer Society , breast cancer is the most common cancer among American women, except for skin cancers. About 1 in 8 women in the U.S. will develop invasive breast cancer during their lifetime. This month, organizations will raise awareness and funding for breast cancer, and it’€™s important that we continue advocating to policy makers, media and the public about the importance of funding research at the level of scientific opportunity. Throughout October, please...

By John Seffrin and Michael Caligiuri An excerpt of an op-ed by John R. Seffrin, PhD, CEO of the American Cancer Society Cancer Action Network and Research!America Board member, and Michael A. Caligiuri, MD, director of the Ohio State University Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute published in U.S News & World Report . Michael A. Caligiuri, MD John R. Seffrin, PhD Clinical trials are often a patient’€™s only viable treatment option for surviving cancer ’€“ a disease that kills 1,500 people every day in this country. But haphazard federal budget cuts, a consequence of the so-called “sequester” that was initiated in March,...